Divis Laboratories Ltd | DIVI - Equity Capital And Reserves

Stock Price
6,915.50
Daily Change
80.50 1.18%
Monthly
10.12%
Yearly
7.18%
Q2 Forecast
6,615.83

Divis Laboratories Ltd reported INR154.13B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 1.29M 865K Mar/2026
Aurobindo Pharma INR 350.34B 23.87B Sep/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Dianthus Therapeutics USD 1.2B 707.91M Mar/2026
Divis Laboratories Ltd INR 154.13B 4.44B Sep/2025
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Lupin INR 224.48B 28.16B Mar/2026
Moderna USD 7.41B 1.24B Mar/2026
Organon & Co USD 903M 151M Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
Tectonic Therapeutic USD 230.42M 20.91M Mar/2026
Tilray USD 1.58B 39.08M Sep/2025
Viatris USD 14.66B 53.6M Mar/2026
Xeris Pharmaceuticals USD 13.01M 678K Mar/2026